Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Cancer Research

• Publication date

  1993-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8504432
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation.

  1993cited by this paper
• Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.

  1993cited by this paper
• Vascular Permeability Factor, Fibrin, and the Pathogenesis of Tumor Stroma Formation a

  1992cited by this paper
• Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.

  1992cited by this paper
• Development of time-resolved immunofluorometric assay of vascular permeability factor.

  1992influential reference
• Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.

  1992cited by this paper
• Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo

  1992cited by this paper
• Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing

  1992cited by this paper
• Vascular permeability factor mRNA and protein expression in human kidney.

  1992cited by this paper
• The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

  1991cited by this paper
• Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells.

  1991cited by this paper
• Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor).

  1991cited by this paper
• The fibroblast growth factor family.

  1991cited by this paper
• Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels

  1991cited by this paper
• Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.

  1990cited by this paper
• Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor.

  1990influential reference
• Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration

  1990cited by this paper
• Vascular endothelial growth factor is expressed in rat corpus luteum.

  1990cited by this paper
• The Basic Science of Oncology

  1989cited by this paper
• Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice.

  1989cited by this paper
• Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.

  1989influential reference
• Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family.

  1989cited by this paper
• Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells.

  1989influential reference
• Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

  1989influential reference
• Vascular permeability factor, an endothelial cell mitogen related to PDGF.

  1989cited by this paper
• Human vascular permeability factor. Isolation from U937 cells.

  1989cited by this paper
• Vascular endothelial growth factor is a secreted angiogenic mitogen.

  1989influential reference
• Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition.

  1989cited by this paper
• Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules.

  1988cited by this paper
• Mechanisms of malignant ascites production.

  1987cited by this paper
• A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

  1986cited by this paper
• Malignant Ascites: Clinical and Experimental Observations

  1986cited by this paper
• Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

  1983cited by this paper
• Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products.

  1979cited by this paper
• Pathogenesis of ascites in mice with peritoneal carcinomatosis.

  1976cited by this paper
• Fluid Accumulation during Initial Stages of Ascites Tumor Growth

  1958cited by this paper

• Intraperitoneal Steroid Therapy for Recurrent Malignant Ascites in Advanced Cancer Patients: A Case Series

  2024cites this paper
• Peritoneal Structure and Changes as a Dialysis Membrane After Peritoneal Dialysis

  2021cites this paper
• Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review

  2021cites this paper
• Immunology and Immunotherapy of Ovarian Cancer

  2020cites this paper
• Immunotherapeutic Approaches of Rheumatoid Arthritis and the Implication on Novel Interventions for Refractoriness

  2018cites this paper
• Vascular endothelial growth factor in pleural effusions and correlation with radiologic and biochemical parameters

  2018cites this paper
• Locoregional and Palliative Therapies for Patients with Unresectable Peritoneal Metastases

  2018cites this paper
• New Treatment Modalities for the Management of Peritoneal Metastases

  2018cites this paper
• Investigating the Effect of One Period of Nigella Sativa Nanocapsules Consumption on the Histopathological Structure and Vascular Endothelial Growth Factor Levels of the Lung Tissue of the Rats Exposed to Nicotine-Derived Nitrosamine Ketone

  2018cites this paper
• High circulating angiopoietin-2 levels exacerbate pulmonary inflammation but not vascular leak or mortality in endotoxin-induced lung injury in mice

  2017cites this paper
• Angiopoietin-1 promotes atherosclerosis by increasing the proportion of circulating Gr1+ monocytes

  2017cites this paper
• Dasatinib increases endothelial permeability leading to pleural effusion

  2017cites this paper
• University of Groningen Ovarian cancer gene therapy

  2017cites this paper
• The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment

  2016cites this paper
• Chapter 8: General Discussion

  2016cites this paper
• Intraperitoneal administration of cisplatin plus bevacizumab for the management of malignant ascites in ovarian epithelial cancer: results of a phase III clinical trial

  2015cites this paper
• Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions.

  2015cites this paper
• Differential expression of vascular endothelial growth factor-A, -C and -D for the diagnosis and prognosis of cancer patients with malignant effusions.

  2015cites this paper
• Tumors: Wounds That Do Not Heal—Redux

  2015cites this paper
• Hypoxia and Breast Cancer Metastasis

  2014cites this paper
• Pilot Study of Intraperitoneal Administration of Triamcinolone Acetonide for Cancerous Ascites in Patients With End-Stage Gynecological Cancer

  2014cites this paper
• Relationship between vascular endothelial growth factor and left ventricular dimension in patients with acute myocardial infarction.

  2014cites this paper
• The Role of Vascular Endothelial Growth Factor in the Pathogenesis, Diagnosis and Treatment of Malignant Pleural Effusion

  2013cites this paper
• Matrix protein of vesicular stomatitis virus: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation

  2013cites this paper
• Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis.

  2012cites this paper
• Potential role of AQP1 and VEGF in the development of malignant pleural effusion in mice

  2012cites this paper
• In search of new prognostic molecular markers in ovarian cancer

  2012cites this paper
• Die Rolle des VEGF im Ovarialkarzinom

  2011cites this paper
• Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer

  2011cites this paper
• Experimentelle Untersuchungen zur Bedeutung von Wachstums- und Gerinnungsfaktoren bei der Entstehung maligner Ergüsse

  2010cites this paper
• Advances in the investigation and treatment of pleural effusions

  2010cites this paper
• Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice

  2010cites this paper
• Role of viral induced vascular endothelial growth factor (VEGF) production in pleural effusion and malignant mesothelioma

  2009influential citation
• Malignant pleural disease in primary lung cancer

  2009cites this paper
• The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer

  2009cites this paper
• Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?

  2009cites this paper
• Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer.

  2009cites this paper
• THE NEED FOR TARGETED THERAPIES TO SUPPRESS THE FORMATION OF MALIGNANT ASCITES Growth of tumors in serous cavities

  2009cites this paper
• Venodilatory effect of vascular endothelial growth factor on rat gingiva.

  2009cites this paper
• Functional Structure of the Peritoneum as a Dialyzing Membrane

  2009cites this paper
• Review of the role of the plasminogen activator system and vascular endothelial growth factor in subfertility.

  2008cites this paper
• Positive Feedback between Vascular Endothelial Growth Factor-A and Autotaxin in Ovarian Cancer Cells

  2008cites this paper
• The Involvement of the Cyclooxygenase Enzymes in the Gallus Domesticus Model of Ovarian Cancer

  2008cites this paper
• The development of novel therapies for rheumatoid arthritis

  2008cites this paper
• Repeated Thoracenteses Affect Proinflammatory Cytokines, Vascular Endothelial Growth Factor, and Fibrinolytic Activity in Pleural Transudates

  2007cites this paper
• Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer

  2007influential citation
• Human subfertility : explorative studies on some pathophysiologic factors in semen and follicular fluid

  2007cites this paper
• Le VEGF en physiologie et pathologie thyroïdienne

  2007cites this paper
• Novel approaches in advancing the treatment of epithelial ovarian cancer: the role of angiogenesis inhibition.

  2007cites this paper
• [Gustave Roussy's (1874-1948) contribution to neuroendocrinology].

  2007cites this paper
• Neoplastic Human Ovaries Vascular Permeability Factor Gene Expression in Normal and Updated

  2007influential citation
• VEGF in physiological process and thyroid disease.

  2007cites this paper
• VEGF in physiological process and thyroid disease Le VEGF en physiologie et pathologie thyroïdienne

  2007cites this paper
• Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts.

  2006cites this paper
• Angiogenesis and inflammation in skeletal muscle in response to ascites tumor in mice.

  2006cites this paper
• Estrogen Receptor β Inhibits Angiogenesis and Growth of T47D Breast Cancer Xenografts

  2006cites this paper
• Inhibition of Tumor Growth and Metastasis by an Immunoneutralizing Monoclonal Antibody to Human Vascular Endothelial Growth Factor/Vascular Permeability Factor121

  2006cites this paper
• 16 - Role of Immunohistochemical Expression of Vascular Endothelial Growth Factor C and Vascular Endothelial Growth Factor Receptor 2 in Ovarian Cancer

  2006cites this paper
• T 47 D Breast Cancer Xenografts Inhibits Angiogenesis and Growth of β Estrogen Receptor

  2006cites this paper
• Serum Vascular Endothelial Growth Factor in Pediatric Patients with Community-Acquired Pneumonia and Pleural Effusion

  2006cites this paper
• Estudio de la angiogénesis en la patología pleural y su asociación con los marcadores de actividad neutrofílica, el sistema de la fibrinolisis y la matriz extracelular

  2005cites this paper
• Ovarian cancer gene therapy

  2005cites this paper
• Angiogenic Factors and Angiogenesis Inhibitors in Exudative Pleural Effusions

  2005cites this paper
• Vascular endothelial growth factor and its soluble receptor in ovarian pathology

  2005cites this paper
• Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.

  2005cites this paper
• [Vascular endothelial growth factor in benign and malignant pleural effusions].

  2005cites this paper
• Cancer-derived VEGF plays no role in malignant ascites formation in the mouse.

  2005cites this paper
• El factor de crecimiento endotelial vascular en los derrames pleurales benignos y malignos

  2005cites this paper
• Pleurodesis is inhibited by anti-vascular endothelial growth factor antibody.

  2005cites this paper
• Vascular endothelial growth factor in pleural effusions of different origin

  2005cites this paper
• Vascular endothelial growth factor concentrations in synovial fluids of patients with symptomatic internal derangement of the temporomandibular joint.

  2005cites this paper
• Clinical Significance of VEGF-A, -C and -D Expression in Esophageal Malignancies

  2005cites this paper
• Ovarian cancer gene therapy strategies

  2005cites this paper
• Vascular endothelial growth factor in esophageal cancer

  2004cites this paper
• Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion.

  2004cites this paper
• Targeting Vascular Endothelial Growth Factor (VEGF) for Anti-tumor Therapy, by Anti-VEGF Neutralizing Monoclonal Antibodies or by VEGF Receptor Tyrosine-kinase Inhibitors

  2004cites this paper
• VEGF in Esophageal Cancer

  2004cites this paper
• Interplay between inflammation and tumor angiogenesis

  2004cites this paper
• Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites

  2004cites this paper
• Tumor angiogenesis: the pivotal role of vascular endothelial growth factor

  2004cites this paper
• Receptor Tyrosine Kinases as Therapeutic Targets in Solid Tumors

  2003cites this paper
• Relation between the expression of vascular endothelial growth factor in synovial tissues and the extent of joint effusion seen on magnetic resonance imaging in patients with internal derangement of the temporomandibular joint.

  2003cites this paper
• Vascular endothelial growth factor in females of reproductive age

  2003cites this paper
• Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor.

  2003cites this paper
• Vascular endothelial growth factor in adnexal masses

  2003cites this paper
• Host microenvironment in breast cancer development: Inflammatory and immune cells in tumour angiogenesis and arteriogenesis

  2003cites this paper
• Diagnostic Value of C-Veactive Protein and Vascular Endothelial Growth Factor in Differentiation of Pleural Effusions

  2003cites this paper
• Angiogenesis in epithelian ovarian cancer

  2002cites this paper
• Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.

  2002cites this paper
• High Level of Vascular Endothelial Growth Factor in Hemorrhagic Pleural Effusion of Cancer

  2002cites this paper
• Transforming growth factor beta induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro.

  2002cites this paper
• Vascular endothelial growth factor concentrations in body cavity effusions in dogs.

  2002cites this paper
• Transforming Growth Factor β Induces Vascular Endothelial Growth Factor Elaboration from Pleural Mesothelial Cells in Vivo and in Vitro

  2002cites this paper
• Magnetic resonance imaging contrast agents: Theory and the role of dendrimers

  2002cites this paper
• Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor.

  2002cites this paper
• Angiogenesis and metastasis.

  2002cites this paper
• Vascular endothelial growth factor: the key mediator in pleural effusion formation

  2002cites this paper
• Angiogenesis in benign, pre-malignant and malignant vulvar lesions.

  2002cites this paper
• Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.

  2002cites this paper
• Identifying Tumor Vascular Permeability Heterogeneity With Magnetic Resonance Imaging Contrast Agents

  2002influential citation